Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trials

Alexander D. Sherry, Timothy A. Lin, Zachary R. McCaw, Esther J. Beck, Ramez Kouzy, Joseph Abi Jaoude, Adina H. Passy, Avital M. Miller, Gabrielle S. Kupferman, Clifton David Fuller, Charles R. Thomas, Eugene J. Koay, Chad Tang, Pavlos Msaouel, Ethan B. Ludmir

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trials'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases